Pharmacogenomics Market Report 2026
Download Free Sample Buy Now
Pharmacogenomics Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Pharmacogenomics Market Report 2026

Global Outlook – By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, Other Technologies), By Application (Neurological Diseases, Infectious Diseases, Oncology, Cardiovascular Diseases, Pain Management, Other Applications), By End User (Hospitals and Clinics, Research Institutions, Academic Institutes, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Pharmacogenomics Market Overview

• Pharmacogenomics market size has reached to $9.84 billion in 2025

• Expected to grow to $15.98 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%

• Growth Driver: Proliferation Of Chronic Diseases Driving Growth In Pharmacogenomics Market Due To Personalized Medicine Advancements

• Market Trend: Embedding AI-Powered Drug-Drug Interaction Management Through Deep Genomic Insight

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pharmacogenomics Market?

Pharmacogenomics is a field of research that studies how a patient's genes affect and how they respond to medications. The long-term aim of pharmacogenomics is to help doctors select the drugs and doses best suited for each person. Pharmacogenomics is used to create customized drugs to treat a variety of health issues, including cardiovascular disease, Alzheimer's disease, cancer, and asthma. The pharmacogenomics marker refers to precise medical treatment for each person or a group of people.

The main technologies used in the pharmacogenomics market a next-generation sequencing (NGS), polymerase chain reaction, gel electrophoresis, mass spectrometry, microarray, and other technologies. NGS is a massively parallel sequencing technology that provides ultra-high throughput, scalability, and speed. The technology is used to determine the nucleotide order in entire genomes or specific regions of DNA or RNA. The application of pharmacogenomics includes neurological diseases, infectious diseases, oncology, cardiovascular diseases, pain management, and other applications. The end-users included hospitals and clinics, research institutions, academic institutes, and others.

Pharmacogenomics market report bar graph

What Is The Pharmacogenomics Market Size and Share 2026?

The pharmacogenomics market size has grown rapidly in recent years. It will grow from $9.84 billion in 2025 to $10.85 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to increasing genomic research activities, expansion of targeted therapy development, rising prevalence of chronic diseases, improvements in sequencing technologies, growing availability of genetic testing services.

What Is The Pharmacogenomics Market Growth Forecast?

The pharmacogenomics market size is expected to see rapid growth in the next few years. It will grow to $15.98 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to increasing investments in precision medicine programs, rising adoption of AI-driven genomic analysis, expansion of pharmacogenomics in oncology and cardiology, growing focus on individualized drug development, continuous advancements in bioinformatics platforms. Major trends in the forecast period include increasing adoption of personalized medicine approaches, rising use of genetic testing in drug selection, growing integration of pharmacogenomic data in clinical workflows, expansion of companion diagnostics, enhanced focus on precision therapeutics.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Pharmacogenomics Market Segmentation

1) By Technology: Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, Other Technologies

2) By Application: Neurological Diseases, Infectious Diseases, Oncology, Cardiovascular Diseases, Pain Management, Other Applications

3) By End User: Hospitals and Clinics, Research Institutions, Academic Institutes, Other End Users

Subsegments:

1) By Next Generation Sequencing (NGS): Whole Genome Sequencing, Targeted Sequencing, Exome Sequencing

2) By Polymerase Chain Reaction (PCR): Quantitative PCR (qPCR), Reverse Transcription PCR (RT-PCR), Digital PCR

3) By Gel Electrophoresis: Agarose Gel Electrophoresis, Polyacrylamide Gel Electrophoresis, Capillary Gel Electrophoresis

4) By Mass Spectrometry: LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry), MALDI-TOF MS (Matrix-Assisted Laser Desorption/Ionization Time of Flight), HRMS (High-Resolution Mass Spectrometry)

5) By Microarray: SNP Microarrays, Expression Microarrays, Comparative Genomic Hybridization (CGH) Arrays

6) By Other Technologies: Sanger Sequencing, CRISPR-Based Technologies, Bioinformatics Tools

What Is The Driver Of The Pharmacogenomics Market?

The increasing number of chronic diseases is expected to propel the growth of the pharmacogenomics market going forward. Chronic diseases are medical conditions that persist over an extended period, often for a person's lifetime. The rise in chronic diseases is due to the increasing average lifespan of the global population and the widespread adoption of behavioral risk factors such as sedentary lifestyles, poor diet, and tobacco use. Pharmacogenomics offers a personalized approach to the treatment of chronic diseases, taking into account individual genetic variations that impact drug response. For instance, in 2025, according to the International Diabetes Federation, a Belgium-based health organization, in 2024, around 589 million adults aged 20-79 were living with diabetes, with the total number projected to reach 853 million by 2050 and with more than 4 in 5 adults with diabetes residing in low and middle income countries. Therefore, the increasing number of chronic diseases is driving the growth of the pharmacogenomics industry.

Key Players In The Global Pharmacogenomics Market

Major companies operating in the pharmacogenomics market are Illumina Inc, Eurofins Scientific, Myriad Genetics Inc, PerkinElmer Inc, Centogene N.V, Invitae Corporation, Genomind, Pacific Biosciences of California Inc, Oneome LLC, Admera Health, MapMyGenome, Positive Bioscience, Xcode Life Sciences, Takeda Pharmaceutical Company Limited, Garvan Institute of Medical Research, 3D Medicines Inc, Berry Genomics, BGI, GenomiCare Biotechnology, F Hoffmann-La Roche AG, Merck KGaA, QIAGEN N.V, Centro de Genoma e Biologia de Sistemas, Datar Cancer Genetics Limited, MedGenome Labs, 23andMe, Color Genomics, Pathway Genomics, Genomika Diagnósticos

Global Pharmacogenomics Market Trends and Insights

Major companies operating in the pharmacogenomics market are increasingly focusing on artificial intelligence (AI) driven models that manage drug-drug interactions (DDIs) at the genomic level, thereby improving medication safety, reducing adverse reactions, and enabling highly personalized prescribing. AI-powered pharmacogenetics engines refer to advanced digital systems that use artificial intelligence to analyze a person’s genetic profile and predict how they will respond to specific medications. For example, in December 2024, PGxAI, a US-based artificial intelligence (AI) driven pharmacogenetics company, launched its Sirius model, an AI-powered pharmacogenetics engine that personalizes drug selection, dosage, and drug-drug interaction management based on an individual’s genome. Sirius covers 730 drugs and 40 key pharmacogenes, enabling much broader coverage than traditional pharmacogenomic solutions. The model is designed to be used by hospital systems, diagnostic labs, and clinical research organizations, helping to reduce adverse reactions and improve therapeutic outcomes.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Pharmacogenomics Market?

In June 2023, Genomenon, a US-based genomics intelligence company, acquired Boston Genetics for an undisclosed amount. The acquisition aims to combine Genomenon's AI-powered genomic platform with Boston Genetics' team of genetic scientists to curate the entire human genome. This acquisition will support clinical diagnostic and pharmaceutical drug development programs by providing valuable insights into the genomic drivers of genetic diseases and oncology. The acquisition also creates a genomics data service arm for Genomenon, allowing the company to provide cost-effective variant curation team extensions for genetic testing labs to speed up their turnaround times. Boston Genetics is a US-based genomics interpretation and curation company.

Regional Outlook

North America was the largest region in the pharmacogenomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Pharmacogenomics Market?

The pharmacogenomics market includes revenues earned by entities by providing PennCNV, QuantiSNP, GenoCN, and Nexus. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pharmacogenomics Market Report 2026?

The pharmacogenomics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacogenomics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Pharmacogenomics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $10.85 billion
Revenue Forecast In 2035 $15.98 billion
Growth Rate CAGR of 10.3% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Technology, Application, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Illumina Inc, Eurofins Scientific, Myriad Genetics Inc, PerkinElmer Inc, Centogene N.V, Invitae Corporation, Genomind, Pacific Biosciences of California Inc, Oneome LLC, Admera Health, MapMyGenome, Positive Bioscience, Xcode Life Sciences, Takeda Pharmaceutical Company Limited, Garvan Institute of Medical Research, 3D Medicines Inc, Berry Genomics, BGI, GenomiCare Biotechnology, F Hoffmann-La Roche AG, Merck KGaA, QIAGEN N.V, Centro de Genoma e Biologia de Sistemas, Datar Cancer Genetics Limited, MedGenome Labs, 23andMe, Color Genomics, Pathway Genomics, Genomika Diagnósticos
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Pharmacogenomics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Pharmacogenomics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Pharmacogenomics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Pharmacogenomics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Fintech, Blockchain, Regtech & Digital Finance

4.2. Major Trends

4.2.1 Increasing Adoption Of Personalized Medicine Approaches

4.2.2 Rising Use Of Genetic Testing In Drug Selection

4.2.3 Growing Integration Of Pharmacogenomic Data In Clinical Workflows

4.2.4 Expansion Of Companion Diagnostics

4.2.5 Enhanced Focus On Precision Therapeutics

5. Pharmacogenomics Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Research Institutions

5.3 Academic Institutes

5.4 Pharmaceutical Companies

5.5 Biotechnology Companies

6. Pharmacogenomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pharmacogenomics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Pharmacogenomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Pharmacogenomics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Pharmacogenomics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Pharmacogenomics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pharmacogenomics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pharmacogenomics Market Segmentation

9.1. Global Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, Other Technologies

9.2. Global Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Neurological Diseases, Infectious Diseases, Oncology, Cardiovascular Diseases, Pain Management, Other Applications

9.3. Global Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals and Clinics, Research Institutions, Academic Institutes, Other End Users

9.4. Global Pharmacogenomics Market, Sub-Segmentation Of Next Generation Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Whole Genome Sequencing, Targeted Sequencing, Exome Sequencing

9.5. Global Pharmacogenomics Market, Sub-Segmentation Of Polymerase Chain Reaction, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Quantitative PCR (qPCR), Reverse Transcription PCR (RT-PCR), Digital PCR

9.6. Global Pharmacogenomics Market, Sub-Segmentation Of Gel Electrophoresis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Agarose Gel Electrophoresis, Polyacrylamide Gel Electrophoresis, Capillary Gel Electrophoresis

9.7. Global Pharmacogenomics Market, Sub-Segmentation Of Mass Spectrometry, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry), MALDI-TOF MS (Matrix-Assisted Laser Desorption/Ionization Time of Flight), HRMS (High-Resolution Mass Spectrometry)

9.8. Global Pharmacogenomics Market, Sub-Segmentation Of Microarray, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

SNP Microarrays, Expression Microarrays, Comparative Genomic Hybridization (CGH) Arrays

9.9. Global Pharmacogenomics Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Sanger Sequencing, CRISPR-Based Technologies, Bioinformatics Tools

10. Pharmacogenomics Market Regional And Country Analysis

10.1. Global Pharmacogenomics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Pharmacogenomics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pharmacogenomics Market

11.1. Asia-Pacific Pharmacogenomics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pharmacogenomics Market

12.1. China Pharmacogenomics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pharmacogenomics Market

13.1. India Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pharmacogenomics Market

14.1. Japan Pharmacogenomics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pharmacogenomics Market

15.1. Australia Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pharmacogenomics Market

16.1. Indonesia Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pharmacogenomics Market

17.1. South Korea Pharmacogenomics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pharmacogenomics Market

18.1. Taiwan Pharmacogenomics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pharmacogenomics Market

19.1. South East Asia Pharmacogenomics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pharmacogenomics Market

20.1. Western Europe Pharmacogenomics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pharmacogenomics Market

21.1. UK Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pharmacogenomics Market

22.1. Germany Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pharmacogenomics Market

23.1. France Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pharmacogenomics Market

24.1. Italy Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pharmacogenomics Market

25.1. Spain Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pharmacogenomics Market

26.1. Eastern Europe Pharmacogenomics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pharmacogenomics Market

27.1. Russia Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pharmacogenomics Market

28.1. North America Pharmacogenomics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pharmacogenomics Market

29.1. USA Pharmacogenomics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pharmacogenomics Market

30.1. Canada Pharmacogenomics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pharmacogenomics Market

31.1. South America Pharmacogenomics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pharmacogenomics Market

32.1. Brazil Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pharmacogenomics Market

33.1. Middle East Pharmacogenomics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pharmacogenomics Market

34.1. Africa Pharmacogenomics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Pharmacogenomics Market, Segmentation By Technology, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pharmacogenomics Market Regulatory and Investment Landscape

36. Pharmacogenomics Market Competitive Landscape And Company Profiles

36.1. Pharmacogenomics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Pharmacogenomics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Pharmacogenomics Market Company Profiles

36.3.1. Illumina Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Myriad Genetics Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.4. PerkinElmer Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Centogene N.V Overview, Products and Services, Strategy and Financial Analysis

37. Pharmacogenomics Market Other Major And Innovative Companies

Invitae Corporation, Genomind, Pacific Biosciences of California Inc, Oneome LLC, Admera Health, MapMyGenome, Positive Bioscience, Xcode Life Sciences, Takeda Pharmaceutical Company Limited, Garvan Institute of Medical Research, 3D Medicines Inc, Berry Genomics, BGI, GenomiCare Biotechnology, F Hoffmann-La Roche AG

38. Global Pharmacogenomics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pharmacogenomics Market

40. Pharmacogenomics Market High Potential Countries, Segments and Strategies

40.1 Pharmacogenomics Market In 2030 - Countries Offering Most New Opportunities

40.2 Pharmacogenomics Market In 2030 - Segments Offering Most New Opportunities

40.3 Pharmacogenomics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Pharmacogenomics Market, Overview Of Key Products - Product Examples
  • Table 2: Global Pharmacogenomics Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Pharmacogenomics Market, Supply Chain Analysis
  • Table 4: Global Pharmacogenomics Market, Major Raw Material Providers
  • Table 5: Global Pharmacogenomics Market, Major Resource Providers
  • Table 6: Global Pharmacogenomics Market, Major Manufacturers (Suppliers)
  • Table 7: Global Pharmacogenomics Market, Major Distributors And Channel Partners
  • Table 8: Global Pharmacogenomics Market, Key Technologies & Future Trends
  • Table 9: Global Pharmacogenomics Market, Major Trends
  • Table 10: Global Pharmacogenomics Market, Major End Users
  • Table 11: Global Pharmacogenomics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Pharmacogenomics Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Pharmacogenomics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Pharmacogenomics Market - TAM, US$ Billion, 2025
  • Table 15: Global Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Pharmacogenomics Market, Sub-Segmentation Of Next Generation Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Pharmacogenomics Market, Sub-Segmentation Of Polymerase Chain Reaction, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Pharmacogenomics Market, Sub-Segmentation Of Gel Electrophoresis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Pharmacogenomics Market, Sub-Segmentation Of Mass Spectrometry, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Pharmacogenomics Market, Sub-Segmentation Of Microarray, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Pharmacogenomics Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Pharmacogenomics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Pharmacogenomics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Global Pharmacogenomics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 99: Global Pharmacogenomics Market - Company Scoring Matrix
  • Table 100: Illumina Inc Financial Performance
  • Table 101: Eurofins Scientific Financial Performance
  • Table 102: Myriad Genetics Inc Financial Performance
  • Table 103: PerkinElmer Inc Financial Performance
  • Table 104: Centogene N.V Financial Performance
  • Table 105: Global Pharmacogenomics Market, Competitive Benchmarking (In USD Billions)
  • Table 106: Global Pharmacogenomics Market, Competitive Dashboard
  • Table 107: Global Pharmacogenomics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 108: Global, Pharmacogenomics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Table 109: Global, Pharmacogenomics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Table 110: Global, Pharmacogenomics Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

    Figure 1: Global Pharmacogenomics Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Pharmacogenomics Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Pharmacogenomics Market, Supply Chain Analysis
  • Figure 4: Global Pharmacogenomics Market, Major Raw Material Providers
  • Figure 5: Global Pharmacogenomics Market, Major Resource Providers
  • Figure 6: Global Pharmacogenomics Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Pharmacogenomics Market, Major Distributors And Channel Partners
  • Figure 8: Global Pharmacogenomics Market, Key Technologies & Future Trends
  • Figure 9: Global Pharmacogenomics Market, Major Trends
  • Figure 10: Global Pharmacogenomics Market, Major End Users
  • Figure 11: Global Pharmacogenomics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Pharmacogenomics Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Pharmacogenomics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Pharmacogenomics Market - TAM, US$ Billion, 2025
  • Figure 15: Global Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Pharmacogenomics Market, Sub-Segmentation Of Next Generation Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Pharmacogenomics Market, Sub-Segmentation Of Polymerase Chain Reaction, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Pharmacogenomics Market, Sub-Segmentation Of Gel Electrophoresis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Pharmacogenomics Market, Sub-Segmentation Of Mass Spectrometry, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Pharmacogenomics Market, Sub-Segmentation Of Microarray, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Pharmacogenomics Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Pharmacogenomics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Pharmacogenomics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Global Pharmacogenomics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 99: Global Pharmacogenomics Market - Company Scoring Matrix
  • Figure 100: Illumina Inc Financial Performance
  • Figure 101: Eurofins Scientific Financial Performance
  • Figure 102: Myriad Genetics Inc Financial Performance
  • Figure 103: PerkinElmer Inc Financial Performance
  • Figure 104: Centogene N.V Financial Performance
  • Figure 105: Global Pharmacogenomics Market, Competitive Benchmarking (In USD Billions)
  • Figure 106: Global Pharmacogenomics Market, Competitive Dashboard
  • Figure 107: Global Pharmacogenomics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 108: Global, Pharmacogenomics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Figure 109: Global, Pharmacogenomics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Figure 110: Global, Pharmacogenomics Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

2025 Dental 3D Printing Devices Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Dental 3D Printing Devices Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Global 3D Bioprinting Market Projected to Reach $5.04 Billion by 2029 at a CAGR of 23.1%

Read More About Global 3D Bioprinting Market Projected to Reach $5.04 Billion by 2029 at a CAGR of 23.1%

$15.02 Billion Forecast for AI-based Surgical Robots Market by 2029, Backed by Demand and Innovation

Read More About $15.02 Billion Forecast for AI-based Surgical Robots Market by 2029, Backed by Demand and Innovation

Arrhythmia Monitoring Devices Market Forecast Reaching $12.03 Billion by 2029 at 10.2% CAGR

Read More About Arrhythmia Monitoring Devices Market Forecast Reaching $12.03 Billion by 2029 at 10.2% CAGR

Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Read More About Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Read More About Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the lichen planus market backed by expert analysis and data-driven projections.

Read More About Discover the latest insights, trends, and market numbers in the lichen planus market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical syringe drive systems market backed by expert analysis and data-driven projections.

Read More About Discover the latest insights, trends, and market numbers in the medical syringe drive systems market backed by expert analysis and data-driven projections.

Population Health Management Market Report 2026 - Global Outlook – By Component (Software, Service), By Mode Of Delivery (On Premise, Cloud-Based), By End-User (Providers, Payers, Other End-Users) - Market Size, Trends, ...

Data Preparation Software Market Report 2026 - Global Outlook – By Type (Cloud Based, Web Based), By Deployment (On-Premise, Hosted), By Pricing Model (Subscription, One-Time), By Functionality (Data Integration, Data Cl...

Motorhome Market Report 2026 - Global Outlook – By Model Type (Class A, Class B, Class C), By Application (Leisure Activities, Business Activities), By End-User (Fleet Owners, Direct Owners) – Market Size, Trends, Strate...

Preparation of Coffee Extracts Market Report 2026 - Global Outlook – By Product (Capsules Or Tablets, Powder, Liquid Green Coffee Bean Extraction ), By Source Type (Green Coffee Beans, Roasted Coffee Beans ), By Nature T...

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report 2026 - Global Outlook – By Product (Gene Therapy, Cell Therapy, Tissue Engineered), By Phase (Phase I, Phase II...

N-Methyl-2-Pyrrolidone (NMP) Market Report 2026 - Global Outlook – By Type (Recycled, Fresh), By Purity (99.90%, 99.50%, Other Purities), By End User (Paints And Coatings, Electronics, Automotive, Chemicals, Pharmaceutic...

Furniture Paint Market Report 2026 - Global Outlook – By Base Type (Oil-Based, Water-Based, Other Types), By Product (Acid Curing Coatings, Nitrocellulose Coatings, Polyurethane Coating), By Application (Residential, Com...

Geophysical Software Service Market Report 2026 - Global Outlook – By Software Type (On-premises, Software As A Service (SaaS)), By Survey Type (Land-Based, Marine-Based, Aerial-Based), By Application (Oil And Gas, Miner...

Frequently Asked Questions

The Pharmacogenomics market was valued at $9.84 billion in 2025, increased to $10.85 billion in 2026, and is projected to reach $15.98 billion by 2030.

The global Pharmacogenomics market is expected to grow at a CAGR of 10.2% from 2026 to 2035 to reach $15.98 billion by 2035.

Some Key Players in the Pharmacogenomics market Include, Illumina Inc, Eurofins Scientific, Myriad Genetics Inc, PerkinElmer Inc, Centogene N.V, Invitae Corporation, Genomind, Pacific Biosciences of California Inc, Oneome LLC, Admera Health, MapMyGeno

Major trend in this market includes: Embedding AI-Powered Drug-Drug Interaction Management Through Deep Genomic Insight. For further insights on this market. request a sample here

North America was the largest region in the pharmacogenomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenomics market report are Asia-Pacific, South

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us